Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase I TTFC-E7SH DNA vaccination in HPV16-positive vulvar intraepithelial neoplasia
NL-OMON27857Phase 1Completed
- Sponsor
- Netherlands Cancer Institute
- Start
- Jun 2014
- Modality
- Prophylactic Vaccines → Vaccines & Immunotherapeutics, DNA Vaccines → Plasmid DNA → DNA Therapeutics → Nucleic Acid Therapeutics
- Countries
- 1
01
Overview
Phase 1, open-label trial of TTFC-E7SH in vulvar intraepithelial neoplasia (VIN), sponsored by Netherlands Cancer Institute. Started Jun 2014; status: completed.
02
Drugs
TTFC-E7SH
03
Conditions
vulvar intraepithelial neoplasia (VIN)
Beyond the preview
Go deeper on NL-OMON27857.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON27857.